OMER Q1 2017 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+65.2% YoY

Gross Profit

$12M97.8% margin

Operating Income

-$13M-103.8% margin

Net Income

-$15M-123.1% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-5.0%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$58M

Total Liabilities

$107M

Stockholders' Equity

-$48M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$7M	+65.2%
Gross Profit	$12M	$7M	+69.0%
Operating Income	-$13M	-$19M	+34.6%
Net Income	-$15M	-$21M	+26.5%